Clinical Trial Update: Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update documenting results for adjunctive brexpiprazole in patients with major depressive disorder who did not adequately respond to ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-08-09